Cathy Wang

1.7k total citations
65 papers, 1.3k citations indexed

About

Cathy Wang is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Cathy Wang has authored 65 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 24 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Cathy Wang's work include Multiple Myeloma Research and Treatments (29 papers), Peptidase Inhibition and Analysis (9 papers) and Protein Degradation and Inhibitors (9 papers). Cathy Wang is often cited by papers focused on Multiple Myeloma Research and Treatments (29 papers), Peptidase Inhibition and Analysis (9 papers) and Protein Degradation and Inhibitors (9 papers). Cathy Wang collaborates with scholars based in United States, Netherlands and China. Cathy Wang's co-authors include Steve W. Cui, Qi Wang, Jiake Xu, Minghao Zheng, Kirk Yip, Mingyong Xie, Huihuang Ding, Qingbin Guo, Glyn O. Phillips and Shaoping Nie and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Cathy Wang

61 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cathy Wang United States 20 552 293 222 204 180 65 1.3k
Chunyan Zhang China 24 702 1.3× 214 0.7× 55 0.2× 135 0.7× 102 0.6× 122 1.8k
Hiroyuki Sumi Japan 21 851 1.5× 144 0.5× 144 0.6× 89 0.4× 274 1.5× 130 1.7k
Yong‐Wan Kim South Korea 22 762 1.4× 236 0.8× 43 0.2× 78 0.4× 136 0.8× 120 1.9k
Zitong Zhao China 19 482 0.9× 137 0.5× 32 0.1× 72 0.4× 103 0.6× 56 1.1k
Dong Xiang China 15 482 0.9× 200 0.7× 32 0.1× 275 1.3× 59 0.3× 29 1.1k
Na Yuan China 22 613 1.1× 111 0.4× 128 0.6× 35 0.2× 64 0.4× 80 1.3k
Petya Dimitrova Bulgaria 20 465 0.8× 102 0.3× 58 0.3× 85 0.4× 197 1.1× 67 1.2k
Zixing Chen China 20 798 1.4× 201 0.7× 434 2.0× 39 0.2× 43 0.2× 151 1.5k
Qingyang Wang China 20 458 0.8× 155 0.5× 43 0.2× 104 0.5× 88 0.5× 83 1.2k
Ming Qi China 17 909 1.6× 129 0.4× 33 0.1× 95 0.5× 174 1.0× 84 1.8k

Countries citing papers authored by Cathy Wang

Since Specialization
Citations

This map shows the geographic impact of Cathy Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Wang more than expected).

Fields of papers citing papers by Cathy Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Wang. The network helps show where Cathy Wang may publish in the future.

Co-authorship network of co-authors of Cathy Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Cathy Wang. A scholar is included among the top collaborators of Cathy Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathy Wang. Cathy Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Finkelstein‐Fox, Lucy, Daniel L. Hall, Giselle K. Perez, et al.. (2022). Testing psychosocial mediators of a mind–body resiliency intervention for cancer survivors. Supportive Care in Cancer. 30(7). 5911–5919. 3 indexed citations
2.
Wang, Cathy, Kanhua Yin, Jin Wang, et al.. (2021). Penetrance of male breast cancer susceptibility genes: a systematic review. Breast Cancer Research and Treatment. 191(1). 31–38. 16 indexed citations
3.
4.
Wang, Rui, et al.. (2020). A flexible nonlinear mixed effects model for HIV viral load rebound after treatment interruption. Statistics in Medicine. 39(15). 2051–2066. 8 indexed citations
5.
Wang, Cathy, Yan Wang, Kevin S. Hughes, Giovanni Parmigiani, & Danielle Braun. (2020). Penetrance of Colorectal Cancer Among Mismatch Repair Gene Mutation Carriers: A Meta-Analysis. JNCI Cancer Spectrum. 4(5). pkaa027–pkaa027. 21 indexed citations
6.
Sanchez, Eric, Mingjie Li, Camilia Soof, et al.. (2019). The anti-myeloma effects of the selective JAK1 inhibitor (INCB052793) alone and in combination in vitro and in vivo. Annals of Hematology. 98(3). 691–703. 13 indexed citations
7.
Boef, Arie den, Martin Jak, Gary Zhang, et al.. (2015). Holistic approach using accuracy of diffraction-based integrated metrology to improve on-product performance, reduce cycle time, and cost at litho. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 9424. 94241E–94241E. 19 indexed citations
8.
Chen, Haiming, Eric Sanchez, Mingjie Li, et al.. (2014). Anti-Myeloma Activity by the Combination of the JAK2 Inhibitor Ruxolitinib with Lenalidomide and Corticosteroids. Blood. 124(21). 2114–2114. 6 indexed citations
9.
Wang, Cathy, et al.. (2014). Python Tools for Visual Studio. 2 indexed citations
10.
Tickner, Jennifer, Shek Man Chim, Cathy Wang, et al.. (2013). Loss of Protein Kinase C-δ Protects against LPS-Induced Osteolysis Owing to an Intrinsic Defect in Osteoclastic Bone Resorption. PLoS ONE. 8(8). e70815–e70815. 26 indexed citations
11.
Sanchez, Eric, Mingjie Li, Jennifer Li, et al.. (2012). CEP-18770 (delanzomib) in combination with dexamethasone and lenalidomide inhibits the growth of multiple myeloma. Leukemia Research. 36(11). 1422–1427. 19 indexed citations
12.
Sanchez, Eric, Jing Shen, Jeffrey A. Steinberg, et al.. (2010). The histone deacetylase inhibitor LBH589 enhances the anti-myeloma effects of chemotherapy in vitro and in vivo. Leukemia Research. 35(3). 373–379. 38 indexed citations
13.
Q, Hu, Elizabeth Fink, Hong Yang, et al.. (2010). Fine Definition of the CXCR4-Binding Region on the V3 Loop of Feline Immunodeficiency Virus Surface Glycoprotein. PLoS ONE. 5(5). e10689–e10689. 15 indexed citations
14.
Sanchez, Eric, Mingjie Li, Jeffrey A. Steinberg, et al.. (2009). The proteasome inhibitor CEP‐18770 enhances the anti‐myeloma activity of bortezomib and melphalan. British Journal of Haematology. 148(4). 569–581. 64 indexed citations
15.
Wang, Vivien, et al.. (2008). A comprehensive look at a new metrology technique to support the needs of lithography performance in near future. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 7140. 71400N–71400N. 3 indexed citations
16.
Campbell, Richard A., Eric Sanchez, Jeffrey A. Steinberg, et al.. (2007). Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acid. British Journal of Haematology. 138(4). 467–478. 37 indexed citations
17.
Yeh, Howard, Haiming Chen, Regina A. Swift, et al.. (2006). Serum pleiotrophin levels are elevated in multiple myeloma patients and correlate with disease status. British Journal of Haematology. 133(5). 526–529. 13 indexed citations
18.
Xu, Jiake, Cathy Wang, Renzhi Han, et al.. (2004). Evidence of reciprocal regulation between the high extracellular calcium and RANKL signal transduction pathways in RAW cell derived osteoclasts. Journal of Cellular Physiology. 202(2). 554–562. 21 indexed citations
19.
Xu, Jiake, Cathy Wang, Kirk Yip, et al.. (2003). Effects of Bafilomycin A1: An inhibitor of vacuolar H (+)‐ATPases on endocytosis and apoptosis in RAW cells and RAW cell‐derived osteoclasts. Journal of Cellular Biochemistry. 88(6). 1256–1264. 86 indexed citations
20.
Wang, Cathy, Marius van Rijnsoever, Fabienne Grieu, et al.. (2003). Prognostic Significance of Microsatellite Instability and Ki-<i>ras</i> Mutation Type in Stage II Colorectal Cancer. Oncology. 64(3). 259–265. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunyan Zhang Breakdown of academic impact, for papers by Hiroyuki Sumi Breakdown of academic impact, for papers by Yong‐Wan Kim Breakdown of academic impact, for papers by Zitong Zhao Breakdown of academic impact, for papers by Dong Xiang Breakdown of academic impact, for papers by Na Yuan Breakdown of academic impact, for papers by Petya Dimitrova Breakdown of academic impact, for papers by Zixing Chen Breakdown of academic impact, for papers by Qingyang Wang Breakdown of academic impact, for papers by Ming Qi
Rankless by CCL
2026